Prophylaxis in von Willebrand disease. Case report Presented by Aziz Eghbali. MD, Pediatric Hematologist & Oncologist, medical university of Arak.Arak.Iran.

Slides:



Advertisements
Similar presentations
The Basics of Hemophilia
Advertisements

Potpourri of bleeding disorders Kimo C. Stine, MD Professor of Pediatrics UAMS Medical Director of the Arkansas Center for Bleeding Disorders and Thrombosis.
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
-HA -HB -Factor XI deficiency -Factor II deficiency -Factor V deficiency -Factor XIII deficiency -Factor VII deficiency Dental problems in Hemophilia.
2 Hemophilia B-Case Report Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences Medical Sciences.
Bleeding and Thrombosis in Children Alice J. Cohen, M.D. Newark Beth Israel Medical Center.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
The Basics of Hemophilia Nursing Working Group National Hemophilia Foundation.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
MLAB 1227: Coagulation Keri Brophy-Martinez
Hemophilia What is Hemophilia? Hemophilia is an inherited bleeding disorder in which there is a deficiency or lack of factor VIII or factor IX clotting.
Clinical Case 3. A 14 year old girl was brought to her GP’s office, complaining of: – weight loss, – dry mouth, – lethargy, – easy fatigability – and.
Upper Gastrointestinal Bleeding. Gastrointestinal (GI) bleeding refers to any bleeding that starts in the gastrointestinal tract. Bleeding may come from.
Hemophilia A  A hereditary bleeding disorder caused by a lack of the blood clotting factor VIII  Located on the X chromosomes  Females have two X chromosomes.
VON WILLEBRAND DISEASE Nairobi, Kenya June 25, 2013.
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
NURSING CARE OF THE CHILD WITH A HEMATOLOGIC ALTERATION.
CHILDHOOD SLE IN THE 21 ST CENTURY THE STATE OF THE ART How do we get the best possible outcome Thomas J. A. Lehman MD Chief, Division of Pediatric rheumatology.
Dyspepsia MAHSA KHODADOOSTAN-- GASTROENTROLOGIST.
Child with hematological dysfunction Emad Al Khatib, RN,MSN,CNS.
Not Simply an Ulcer. A 67-year-old woman experienced a sudden onset of right lower abdominal pain without other associated symptoms.
Hemophilia U & I Inc., USA Payor Education Presentation Last Updated; January, 2012.
Mrs. M. Jansen van Vuuren Universitas Academic Hospital Bloemfontein.
The hemophilias A and B X-linked hereditary blood clotting disorders due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) Identical.
FVIII PRODUCT USAGE IN CLINICAL SETTINGS TSEAC October 31, 2005 Mark Weinstein, Ph.D. Office of Blood Research and Review CBER, FDA.
The Hemophilia Federation of America (HFA) is a national nonprofit organization that assists and advocates for the bleeding disorders community. MISSION.
© 2014 Direct One Communications, Inc. All rights reserved. 1 Expanding Therapeutic Options for Hemophilia A and B: Results of Recent Clinical Trials Holleh.
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
Factor VII Deficiency Diagnosis and Management
4 year old boy comes in with painful, swollen R ankle after having fallen off of a swing 6 hours previously, landing on his knee. No history of bruising;
Inherited bleeding disorder of primary hemostasis.
Good Morning 6 June Uremic Bleeding: Pathogenesis and Therapy 麻醉科 林子富.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Organ Donation & Transplantation EXCI233 Online source: rs/transplantation/overview_of_transplantation.html?qt.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Joseph J.Y. Sung, MD et al. Am J Gastroenterol 2010;105. R3 김민경.
Clinical presentation of a child with abnormal bleeding Dr Barnabas R Atwiine.
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
Fever in childhood. Introduction Commonest reason for admission to hospital in UK Either alone or with associated symptoms Self limiting or life threatening.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Slide 6 Twenty years old male patient with recurrent ear discharge for 5 years. 1- what is the diagnosis? 2- what is the surgical treatment?
Congenital bleeding disorders
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Helicobacter pylori eradication prior bariatric/metabolic surgery
Approach To Bleeding Disorders In Neonates
Multiple choice questions
Warfarin in primary care
Sharing experience in treating with EHL product , Banjarmasin
Hemophilia 2009.
Chapter 18 Disorders of Hemostasis
Hemophilia Brandon Vilorio.
Copyright © 2017 American Academy of Pediatrics.
Lecturer Psychiatry, Mansoura Faculty of Medicine
Anticonvulsants: Valproic acid
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Introduction Discussion Case report References
Contribution by: dr. H. Uchima University Hospital Clinic Barcelona
Contribution by: Prof. Dr. J.J. Kolkman
Congenital bleeding disorders
Successful Coronary Artery Bypass in Types 2M and 2N von Willebrand Disease  Mathieu Fiore, MD, PhD, Marie Tuffigo, MD, Véronique Cahoreau, MD, Pierre.
Nutrition management for peptic ulcer
Hemophilia By: Renee Marie Alta.
Blood Dyscrasias Mrs. Christa Cowen MSN, RN
The child with hematological dysfunction
Periprocedural Management of Patients with Bleeding Disorders
Dilemma.
Many post-MI patients are not receiving optimal therapy
Case 5 Revision surgery after pertrochanteric fracture
Presentation transcript:

Prophylaxis in von Willebrand disease. Case report Presented by Aziz Eghbali. MD, Pediatric Hematologist & Oncologist, medical university of Arak.Arak.Iran

Von Willebrand disease (VWD) Von Willebrand disease (VWD), the most common hereditary bleeding disorder, is divided into three types depending on the quantitative (type 1 and 3) or qualitative (type 2) abnormality of von Willebrand factor (VWF)

Von Willebrand disease (VWD) About 70–80% of VWD patients can be treated with the synthetic product desmopressin, while the others necessitate factor VIII/VWF concentrates. In addition to the treatment of bleeding episodes, therapeutic regimens include short- or long-term prophylaxis.

Prophylaxis in von Willebrand disease Short-term prophylaxis is usually performed to prevent excessive bleeding after surgery or invasive procedures, while long-term prophylaxis may be needed to control recurrent mucosal and joint bleeding complicating the more severe forms of VWD.

Long-term prophylaxis in von Willebrand disease Patients with more severe forms of VWD may have recurrent episodes of mucocutaneous bleeding and also hemarthrosis and hematomas and thus are candidate for long- term secondary prophylaxis. However, whereas prophylaxis in hemophilia has become widespread in recent years, this mode of treatment appears to be practiced only occasionally in VWD patients.

Case Report

An 11-year-old girl, known case of Type III von Willebrand Disease (VWD) had been referred because of recurrent epistaxis and easy bruising,for the first time, when she was 2 years old.

Case Report since that time until 3 years ago, she had been receiving plasma-derived factor VIII and from 3 years ago she has been receiving Humate-P, (VWF/FVIII concentrate), according to her demand.

Case Report Once, She had been referred for upper gastrointestinal bleeding 9 months ago with Hb: 6.5 and sever nodularity in gastric anter zone in endoscopy. Because of that, she had been admitted and had been transfused packed cell and had received Humate-p (60 unit / kg /dose) every 12 hours for 2 weeks.

Case Report Similarly, admitted with upper gastrointestinal bleeding and Hb: 6 about 2months later which was medicated by packed cell and Humate-p for 2 weeks.

Case Report Gastric mucosal biopsy showed no H-pylory infection. She discharged with PPI. She admitted again after 45 days with upper gastrointestinal bleeding and Hb: 4.5 in PICU and transfused packed cell and also received Humate-p for 2 weeks.

Case Report From last admission,about 5 months ago, she has been using Humate-p 3 times a week with dosage of 40 unit / kg / dose until now. Our follow up has shown no drop in Hb and no upper gastrointestinal bleeding.